Study on a Seropharmacological Method for an Effective Antifibrotic Formula
|更新时间:2024-01-04
|
Study on a Seropharmacological Method for an Effective Antifibrotic Formula
Chinese Journal of Experimental Traditional Medical FormulaeVol. 4, Issue 2, Pages: 16-19(1998)
作者机构:
作者简介:
基金信息:
DOI:
CLC:R285.5
Published:1998
稿件说明:
移动端阅览
Liu Chenghai, Liu Ping, Liu Cheng, et al. Study on a Seropharmacological Method for an Effective Antifibrotic Formula[J]. Chinese journal of experimental traditional medical formulae, 1998, 4(2): 16-19.
DOI:
Liu Chenghai, Liu Ping, Liu Cheng, et al. Study on a Seropharmacological Method for an Effective Antifibrotic Formula[J]. Chinese journal of experimental traditional medical formulae, 1998, 4(2): 16-19.DOI:
Study on a Seropharmacological Method for an Effective Antifibrotic Formula
The serum was collected from rats fed on Fuzheng Huayu (FZHY) decoction
and FZHY decoction was lyophilized into powder. And both were incubated with hepatic stellate cells (HSC) and hepatocytes. Then cell morphology and functions were observed to study the seropharmacological methods for antifibrotic traditional Chinese herbs. The results showed that the FZHY powder inhibited cell proliferation and viability. The deactivated rat's sera drawn 1h after FZHY-treatment twice had no cytotoxity
promoted hepatocyte proliferation
and inhibited HSC proliferation. Therefore
this seropharmacological method could be applied for antifibrotic herbal formulae.
Active Components of Chinese Medicine Against Liver Fibrosis Based on PI3K/Akt Signaling Pathway: A Review
Mechanism and Combination Therapy of Berberine in Treatment of Nonalcoholic Fatty liver Disease:A Review
Clinical Efficacy of Gandou Fumu Granules in Intervention of Liver Fibrosis in WD Patients with Phlegm and Blood Stasis Syndrome and Effect on Cuproptosis-related Indicators
Gandouling Regulates PI3K/Akt/mTOR Autophagy Signaling Pathway via LncRNA H19 for Treatment of Wilson Disease Liver Fibrosis
Mechanism of Shugan Huazheng Prescription Against Liver Fibrosis Based on HIF-1α/VEGF/TGF-β1 Pathway
Related Author
YANG Xing
WANG Zhen
LI Shudi
LIU Jiangkai
LI Suling
WANG Xiaojie
ZHANG Heng
LIU Sutong
Related Institution
Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine
Henan General Hospital
The First Clinical Medical College of Henan University of Chinese Medicine
The First Affiliated Hospital of Anhui University of Chinese Medicine